TrialInvestigational new drugs2006

Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: a National Cancer Institute of Canada Clinical Trials Group investigational new drug study.

Eric Winquist et al.PubMed ↗Publisher ↗

No numbers read from the abstract.